Aktis Oncology Reports Financial Results and Business Highlights for First Quarter 2026

Go back to Aktis Oncology Reports Financial Results and Business Highlights for First Quarter 2026
(NASDAQ: AKTS) Delayed: 24.79 --0 (-0%)
Previous Close $24.79    52 Week High $5.77 
Open $24.79    52 Week Low $1.51 
Day High $24.79    P/E N/A 
Day Low $24.79    EPS $0.00 
Volume 741